President and Chief Financial Officer
Vikas Sinha is President and CFO of AlloVir, to which he brings more than 25 years of experience in executive finance roles in the life sciences industry. Vikas is also CFO and co-founder of ElevateBio LLC, a holding company focused on building cell and gene therapy companies. AlloVir is an ElevateBio portfolio company.
Previously, Vikas served as the CFO of Alexion Pharmaceuticals for 11 years and was responsible for finance, business development, strategy and IT. During his tenure as CFO, Alexion’s market cap grew from $600 million to more than $30 billion and revenue grew from zero to more than $3 billion.
Prior to joining Alexion, Vikas held various positions with Bayer AG in the United States, Japan, Germany and Canada, including Vice President and CFO of Bayer Pharmaceuticals Corporation, USA, Vice President and Chief Financial Officer of Bayer Yakuhin Ltd., in Japan. He serves as a Managing Partner of MPM Capital, and as an independent board member and Audit Committee chair of Verona Pharma Inc.
Vikas received his M.B.A. from the Asian Institute of Management, Manila, Philippines. He is a qualified Chartered Accountant and associate member of the Institute of Chartered Accountants of India and a Certified Public Accountant in the United States.